• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 1:31:18 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care
    Get the next $MCK alert in real time by email
    SC 13G/A 1 tm216465d13_sc13ga.htm SCHEDULE 13G/A

     

    CUSIP No: 58155Q103

     

     

      SECURITIES AND EXCHANGE COMMISSION  
      Washington, D.C. 20549  

     

     

     

    SCHEDULE 13G

     

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO § 240.13d-2.

     

    (Amendment No. 1)*

     

    McKesson Corporation

    (Name of Issuer)

     

    Common Stock, $0.01 par value per share

    (Title of Class of Securities)

     

    58155Q103

    (CUSIP Number)

     

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ¨ Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No: 58155Q103

     

      (1) Names of Reporting Persons
    Capital Ventures International
       
      (2) Check the Appropriate Box if a Member of a Group (See Instructions)
        (a)   ¨
        (b)   ¨
       
      (3) SEC Use Only
       
      (4) Citizenship or Place of Organization
    Cayman Islands
           
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    0 (1)(2)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
    0 (1)(2)
     
    (8) Shared Dispositive Power
    865,164 (1)
       
      (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
       
      (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
       
      (11) Percent of Class Represented by Amount in Row (9)
    0.5%
       
      (12) Type of Reporting Person (See Instructions)
    CO
               

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

    (2) Susquehanna Advisors Group, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over the shares directly owned by Capital Ventures International.

     

     

     

     

    CUSIP No: 58155Q103

     

    (1) Names of Reporting Persons
    Susquehanna Advisors Group, Inc.
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)   ¨
      (b)   ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Pennsylvania
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    0 (1)(2)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
     0 (1)(2)
     
    (8) Shared Dispositive Power
    865,164 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    0.5%
     
    (12) Type of Reporting Person (See Instructions)
    CO
           

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

    (2) Susquehanna Advisors Group, Inc. is the investment manager to Capital Ventures International and as such may exercise voting and dispositive power over the shares directly owned by Capital Ventures International.

     

     

     

     

    CUSIP No: 58155Q103

     

      (1) Names of Reporting Persons
    Darby Financial Products
     
      (2) Check the Appropriate Box if a Member of a Group (See Instructions)
        (a)   ¨
        (b)   ¨
     
      (3) SEC Use Only
     
      (4) Citizenship or Place of Organization
    Delaware
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    71,700 (1)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
    71,700 (1)
     
    (8) Shared Dispositive Power
    865,164 (1)
     
      (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
     
      (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
      (11) Percent of Class Represented by Amount in Row (9)
    0.5%
     
      (12) Type of Reporting Person (See Instructions)
    PN
               

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

    CUSIP No: 58155Q103

     

    (1) Names of Reporting Persons
    G1 Execution Services, LLC
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)   ¨
      (b)   ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Illinois
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    1,370 (1)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
    1,370 (1)
     
    (8) Shared Dispositive Power
    865,164 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    0.5%
     
    (12) Type of Reporting Person (See Instructions)
    BD, OO
           

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

    CUSIP No: 58155Q103

     

      (1) Names of Reporting Persons
    Susquehanna Fundamental Investments, LLC
     
      (2) Check the Appropriate Box if a Member of a Group (See Instructions)
        (a)   ¨
        (b)   ¨
     
      (3) SEC Use Only
     
      (4) Citizenship or Place of Organization
    Delaware
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    172,700 (1)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
    172,700 (1)
     
    (8) Shared Dispositive Power
    865,164 (1)
     
      (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
     
      (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
      (11) Percent of Class Represented by Amount in Row (9)
    0.5%
     
      (12) Type of Reporting Person (See Instructions)
    OO
               

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

    CUSIP No: 58155Q103

     

    (1) Names of Reporting Persons
    Susquehanna Investment Group
     
    (2) Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)   ¨
      (b)   ¨
     
    (3) SEC Use Only
     
    (4) Citizenship or Place of Organization
    Pennsylvania
         
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    200 (1)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
    200 (1)
     
    (8) Shared Dispositive Power
    865,164 (1)
     
    (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
     
    (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
     
    (11) Percent of Class Represented by Amount in Row (9)
    0.5%
     
    (12) Type of Reporting Person (See Instructions)
    BD, PN
           

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

    CUSIP No: 58155Q103

     

      (1) Names of Reporting Persons
    Susquehanna Securities, LLC
       
      (2) Check the Appropriate Box if a Member of a Group (See Instructions)
        (a)   ¨
        (b)   ¨
       
      (3) SEC Use Only
       
      (4) Citizenship or Place of Organization
    Delaware
           
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    (5) Sole Voting Power
    619,194 (1)
     
    (6) Shared Voting Power
    865,164 (1)
     
    (7) Sole Dispositive Power
    619,194 (1)
     
    (8) Shared Dispositive Power
    865,164 (1)
       
      (9) Aggregate Amount Beneficially Owned by Each Reporting Person
    865,164 (1)
       
      (10) Check box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
       
      (11) Percent of Class Represented by Amount in Row (9)
    0.5%
       
      (12) Type of Reporting Person (See Instructions)
    BD, OO
               

     

    (1) G1 Execution Services, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC are affiliated independent broker-dealers which, together with Capital Ventures International, Darby Financial Products, Susquehanna Advisors Group, Inc., and Susquehanna Fundamental Investments, LLC, may be deemed a group.  For purposes of this report, we have indicated that each reporting person has sole voting and dispositive power with respect to the shares beneficially owned by it and that the reporting persons have shared voting and dispositive power with respect to all shares beneficially owned by all of the reporting persons.  Each of the reporting persons disclaims beneficial ownership of shares owned directly by another reporting person.

     

     

     

     

     

    CUSIP No: 58155Q103

     

    Item 1.

      (a)

    Name of Issuer

     

    McKesson Corporation (the “Company”)

      (b)

    Address of Issuer’s Principal Executive Offices

    6555 State Hwy 161, Irving, TX 75039

     
    Item 2(a).  

    Name of Person Filing

     

    This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons” with respect to the shares of common stock, $0.01 par value per share, of the Company (the “Shares”).

     

    (i)            Capital Ventures International

    (ii)           Susquehanna Advisors Group, Inc.

    (iii)          Darby Financial Products

    (iv)          G1 Execution Services, LLC

    (v)           Susquehanna Fundamental Investments, LLC

    (vi)          Susquehanna Investment Group

    (vii)         Susquehanna Securities, LLC

     

    Item 2(b).  

    Address of Principal Business Office or, if none, Residence

     

    The address of the principal business office of Capital Ventures International is:

     

    P.O. Box 897

    Windward 1, Regatta Office Park

    West Bay Road

    Grand Cayman, KY1-1103

    Cayman Islands

     

    The address of the principal business office of G1 Execution Services, LLC is:

     

    175 W. Jackson Blvd.

    Suite 1700

    Chicago, IL 60604

     

    The address of the principal business office of each of Darby Financial Products, Susquehanna Advisors Group, Inc., Susquehanna Fundamental Investments, LLC, Susquehanna Investment Group and Susquehanna Securities, LLC is:

     

    401 E. City Avenue

    Suite 220

    Bala Cynwyd, PA 19004

    Item 2(c).   Citizenship
    Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
    Item 2(d).   Title of Class of Securities
    Common stock, $0.01 par value per share

     

     

     

     

    CUSIP No: 58155Q103

     

    Item 2(e)  

    CUSIP Number

    58155Q103

     
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
       
      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ¨ A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with rule 13d–1(b)(1)(ii)(K).
          If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:                                     
               

     

    Item 4. Ownership
       
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
     

    The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

     

    The number of Shares reported as beneficially owned by Darby Financial Products includes options to buy 71,700 Shares. The number of Shares reported as beneficially owned by Susquehanna Investment Group includes options to buy 200 Shares. The number of Shares reported as beneficially owned by Susquehanna Securities includes options to buy 310,700 Shares.

     

    The Company’s Quarterly Report on Form 10-Q, filed on November 3, 2020, indicates that there were 160,564,425 Shares outstanding as of November 3, 2020. 

     

    Item 5. Ownership of Five Percent or Less of a Class
       
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:   x

     

     

     

     

    CUSIP No: 58155Q103

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person
    Not applicable.
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
    Not applicable.
     
    Item 8. Identification and Classification of Members of the Group
    Not applicable.
     
    Item 9. Notice of Dissolution of Group
    Not applicable.

     

    Item 10. Certification
       
    By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

    CUSIP No: 58155Q103

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

     

    Dated: February 10, 2021

     

    CAPITAL VENTURES INTERNATIONAL   SUSQUEHANNA ADVISORS GROUP, INC.
         
    By: Susquehanna Advisors Group, Inc. pursuant to a Limited Power of Attorney, a copy of which was previously filed    
         
    By: /s/ Brian Sopinsky   By: /s/ Brian Sopinsky
    Name: Brian Sopinsky   Name:    Brian Sopinsky
    Title: Assistant Secretary   Title: Assistant Secretary

     

    DARBY FINANCIAL PRODUCTS    
         
    By: /s/ Brian Sopinsky    
    Name:    Brian Sopinsky    
    Title: Authorized Signatory    
         
    G1 EXECUTION SERVICES, LLC    
         
    By: /s/ Brian Sopinsky    
    Name: Brian Sopinsky    
    Title: Secretary    
         
    SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC    
         
    By: /s/ Brian Sopinsky    
    Name: Brian Sopinsky    
    Title: Assistant Secretary    

     

    SUSQUEHANNA INVESTMENT GROUP   SUSQUEHANNA SECURITIES, LLC
         
    By: /s/ Brian Sopinsky   By: /s/ Brian Sopinsky
    Name: Brian Sopinsky   Name:    Brian Sopinsky
    Title: General Counsel   Title: Secretary

     

     

     

     

    CUSIP No: 58155Q103

     

    EXHIBIT INDEX

     

    EXHIBIT   DESCRIPTION

     

    I

     

     

    Limited Power of Attorney executed by Capital Ventures International in favor of Susquehanna Advisors Group, Inc., dated as of December 4, 2012*

         

    II 

     

    Joint Filing Agreement 

     

    *Previously filed

     

     

     

     

    CUSIP No: 58155Q103

     

    Exhibit II

     

    JOINT FILING AGREEMENT

     

    This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the common stock of McKesson Corporation, $0.01 par value per share, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

     

    Dated: February 10, 2020

     

    CAPITAL VENTURES INTERNATIONAL   SUSQUEHANNA ADVISORS GROUP, INC.
         
    By: Susquehanna Advisors Group, Inc. pursuant to a Limited Power of Attorney    
         
    By: /s/ Brian Sopinsky   By: /s/ Brian Sopinsky
    Name: Brian Sopinsky   Name:    Brian Sopinsky
    Title: Assistant Secretary   Title: Assistant Secretary

     

    DARBY FINANCIAL PRODUCTS    
         
    By: /s/ Brian Sopinsky    
    Name:    Brian Sopinsky    
    Title: Authorized Signatory    
         
    G1 EXECUTION SERVICES, LLC    
         
    By: /s/ Brian Sopinsky    
    Name: Brian Sopinsky    
    Title: Secretary    
         
    SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC    
         
    By: /s/ Brian Sopinsky    
    Name: Brian Sopinsky    
    Title: Assistant Secretary    

     

    SUSQUEHANNA INVESTMENT GROUP   SUSQUEHANNA SECURITIES, LLC
         
    By: /s/ Brian Sopinsky   By: /s/ Brian Sopinsky
    Name: Brian Sopinsky   Name:    Brian Sopinsky
    Title: General Counsel   Title: Secretary

     

     

     

    Get the next $MCK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MCK

    DatePrice TargetRatingAnalyst
    12/4/2024$630.00Neutral
    Mizuho
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    9/5/2024$670.00 → $665.00Outperform
    Leerink Partners
    8/8/2024$540.00 → $570.00Neutral
    Mizuho
    2/26/2024$600.00Outperform
    Leerink Partners
    1/3/2024$537.00Overweight
    Barclays
    12/14/2023$502.00Equal Weight
    Wells Fargo
    More analyst ratings

    $MCK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions

      McKesson Corporation (NYSE:MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inves

      5/8/25 4:10:00 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Declares Quarterly Dividend

      The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on July 1, 2025, to stockholders of record on June 2, 2025. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read

      5/1/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC

      Announces fourth quarter and full year fiscal 2025 earnings release date McKesson Corporation (NYSE:MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leading provider of general ophthalmology and retina management services. McKesson acquired an approximate 80% controlling interest in PRISM Vision Holdings, an ophthalmology and retina management services provider, for about $850 million. PRISM physicians will retain an approximate 20% interest. The acquisition enables McKesson to develop a leading retinal and ophthalmology platform and expand McKesson's differentiated value proposition, clinical services a

      4/2/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $MCK
    Financials

    Live finance-specific insights

    See more
    • McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions

      McKesson Corporation (NYSE:MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inves

      5/8/25 4:10:00 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Declares Quarterly Dividend

      The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on July 1, 2025, to stockholders of record on June 2, 2025. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read

      5/1/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC

      Announces fourth quarter and full year fiscal 2025 earnings release date McKesson Corporation (NYSE:MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leading provider of general ophthalmology and retina management services. McKesson acquired an approximate 80% controlling interest in PRISM Vision Holdings, an ophthalmology and retina management services provider, for about $850 million. PRISM physicians will retain an approximate 20% interest. The acquisition enables McKesson to develop a leading retinal and ophthalmology platform and expand McKesson's differentiated value proposition, clinical services a

      4/2/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $MCK
    Leadership Updates

    Live Leadership Updates

    See more
    • McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core Ventures

      Acquisition enhances McKesson's integrated oncology platform; Florida Cancer Specialists & Research Institute to join The US Oncology Network McKesson Corporation (NYSE:MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists & Research Institute, LLC (FCS), a leading physician-owned community oncology practice. FCS physicians will continue to retain a minority interest in Core Ventures. McKesson will purchase its controlling interest for approximately $2.49 bil

      8/26/24 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

      KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced that Edward Wholihan was appointed to the Company's Board of Directors on September 28, 2023 to fill the vacancy that followed the Company's 2023 Annual Meeting of Shareholders. "I am extremely proud to welcome a highly accomplished executive such as Ed to our Board of Directors. He will be a valuable addition and we will benefit from his breadth of experience and success creating shar

      10/4/23 4:05:00 PM ET
      $KRMD
      $MCK
      Medical/Dental Instruments
      Health Care
      Other Pharmaceuticals
    • Gentherm Announces Dr. Ken Washington as New Independent Director

      NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023. Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technol

      10/2/23 8:00:00 AM ET
      $AMZN
      $F
      $MCK
      $MDT
      Catalog/Specialty Distribution
      Consumer Discretionary
      Auto Manufacturing
      Other Pharmaceuticals

    $MCK
    SEC Filings

    See more
    • McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MCKESSON CORP (0000927653) (Filer)

      5/8/25 4:06:16 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 144 filed by McKesson Corporation

      144 - MCKESSON CORP (0000927653) (Subject)

      2/28/25 11:26:50 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 144 filed by McKesson Corporation

      144 - MCKESSON CORP (0000927653) (Subject)

      2/25/25 9:51:41 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $MCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Tyler Brian S. sold $5,684,059 worth of shares (8,962 units at $634.24), decreasing direct ownership by 17% to 42,741 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      3/7/25 3:30:44 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SVP, Controller & CAO Rutledge Napoleon B Jr converted options into 786 shares and covered exercise/tax liability with 243 shares, increasing direct ownership by 28% to 2,515 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      3/3/25 4:49:22 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Tyler Brian S. sold $5,591,664 worth of shares (8,961 units at $624.00), decreasing direct ownership by 15% to 51,703 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      3/3/25 4:48:46 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $MCK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mizuho resumed coverage on McKesson with a new price target

      Mizuho resumed coverage of McKesson with a rating of Neutral and set a new price target of $630.00

      12/4/24 7:43:38 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded McKesson from Neutral to Outperform and set a new price target of $688.00 from $531.00 previously

      11/7/24 6:29:13 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded McKesson from Outperform to Neutral and set a new price target of $531.00 from $603.00 previously

      9/24/24 8:19:53 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $MCK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by McKesson Corporation (Amendment)

      SC 13G/A - MCKESSON CORP (0000927653) (Subject)

      2/13/24 5:09:38 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by McKesson Corporation (Amendment)

      SC 13G/A - MCKESSON CORP (0000927653) (Subject)

      1/25/24 1:48:52 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by McKesson Corporation (Amendment)

      SC 13G/A - MCKESSON CORP (0000927653) (Subject)

      2/10/22 8:27:59 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care